Q32 Bio Inc. Share Price
QTTBQ32 Bio Inc. Stock Performance
Open $4.07 | Prev. Close $4.33 | Circuit Range N/A |
Day Range $4.07 - $4.69 | Year Range $1.34 - $6.31 | Volume 5,522 |
Average Traded $4.49 |
Q32 Bio Inc. Share Price Chart
About Q32 Bio Inc.
Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human antiinterleukin-7 receptor alpha antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition. The company was founded in 2017 and is based in Waltham, Massachusetts.
Q32 Bio Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Feb-26 | $4.07 | $4.24 | +11.58% |
05-Feb-26 | $4.00 | $3.80 | -5.00% |
04-Feb-26 | $4.15 | $4.00 | -4.76% |
03-Feb-26 | $4.12 | $4.20 | +6.06% |
02-Feb-26 | $3.95 | $3.96 | +0.25% |
30-Jan-26 | $4.04 | $3.95 | -1.72% |
29-Jan-26 | $3.91 | $4.02 | +3.05% |